Get the alert the day MetaMask files or prices. Segmara Pro, 7-day free trial.
As of September 27, 2026, no S-1 or F-1 registration statement for MetaMask or Consensys appears on SEC EDGAR, and no IPO date has been set. Fortune reported on September 9, 2026 that Consensys is splitting into two companies: the consumer-facing MetaMask wallet becomes an independent entity led by CEO Joe Lubin, while the institutional software business keeps the Consensys name under CEO Mike Kriak. The same report said Consensys had signaled plans a year earlier to go public in early 2026, plans that were shelved amid a crypto-market downturn. Lubin declined to give a renewed IPO timeline, but Fortune reported he suggested the newly standalone MetaMask entity could seek a listing 'as soon as early 2027.' That is a stated possibility from Lubin, not a filing or a scheduled date. Track SEC EDGAR and MetaMask's own channels directly, not secondary chatter.
segmara.com publishes educational private-market context and can route limited interest into account-based private follow-up. Public pages do not create an offer, allocation, payment instruction, investment advice, or issuer-affiliated workflow.
Fortune reported on September 9, 2026 that Consensys is splitting into two companies. The consumer-facing MetaMask wallet becomes an independent entity led by CEO Joe Lubin, while the institutional software business keeps the Consensys name under CEO Mike Kriak.
That is a restructuring announcement, not a registration statement. No S-1 or F-1 for MetaMask or Consensys appears on SEC EDGAR, and the report did not include a filing or a scheduled listing date.
The same September 9, 2026 Fortune report said Consensys had signaled plans a year earlier to go public in early 2026. Those plans were shelved amid a crypto-market downturn.
Lubin declined to give a renewed IPO timeline when asked, but Fortune said he suggested the newly standalone MetaMask entity could seek a listing 'as soon as early 2027.' That is Lubin's stated possibility, not a confirmed date.
A specific IPO date requires more than an executive's comment about timing. The verifiable steps are a confidential or public S-1 or F-1 registration statement filed with the SEC, visible on SEC EDGAR, or an on-the-record date from MetaMask or Consensys leadership. Neither exists as of the latest site review, and any specific 'MetaMask IPO date' circulating online remains speculation until the company or a filing says otherwise.
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
| Metric | Value | Context |
|---|---|---|
| Canonical route | /blog/when-will-metamask-ipo | Stable URL path for AI and search extraction. |
| Article title | When Will MetaMask IPO? Split From Consensys, 2027 Not Confirmed | Main page topic. |
| Attached public sources | 1 | Number of citation links rendered at the bottom of the article. |
| Segmara listed companies | 51 | Live private-company listings in the public catalogue. |
| Priced listings | 37 | Catalogue listings with visible indicative or direct marks. |
| Request-quote listings | 14 | Catalogue listings where a public price is intentionally not invented. |
| Stage | Timing | Price / valuation signal | Interpretation |
|---|
| Chart metric | Score | Interpretation |
|---|---|---|
| Catalogue breadth | 100 / 100 | 51 public listings |
| Visible pricing coverage | 72 / 100 | 37 of 51 listings show a mark |
| Source depth | 38 / 100 | 1 source links |
The search behind 'When Will MetaMask IPO? Split From Consensys, 2027 Not Confirmed' is an access-intent query. People want to know where they can start interest in MetaMask private-market exposure without needing a private equity relationship, fund connection, or insider network.
segmara.com turns that search into a simple path: browse the listing, create an account, choose the company, and start the private-share inquiry. Final pricing and availability still depend on the route, but the starting point is public and straightforward.
Segmara works as a private-market access layer for interested visitors. The site helps visitors discover private markets categories that were previously hard to research and moves them into an account-based inquiry in a few steps.
Illustrative map of where the old private-market process was hardest and where Segmara makes the starting point easier.
SEGMARA PRO
Free: every article, the IPO calendar and the weekly IPOs page. Pro: same-day filing alerts and the weekly brief on all 99 companies, with a 7-day free trial, then $15 a month. Research only, no share sales.
Yes. Visitors can start with the free MetaMask tracker using email only, then decide whether a private follow-up makes sense. Availability, eligibility, pricing, allocation, transfer approval, documents, and final terms can still vary by route.
Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes the starting point simpler: visitors can follow named private-company interest before any account, document upload, or payment step.
Open the free MetaMask tracker first. It is email-only and keeps the public step narrow while final availability, pricing, eligibility, and terms are handled only through private follow-up.
No. As of the latest site review, no S-1 or F-1 for MetaMask appears on SEC EDGAR. Fortune reported on September 9, 2026 that CEO Joe Lubin declined to give a renewed IPO timeline, though he suggested a listing could come 'as soon as early 2027' once MetaMask operates as an independent entity.
Fortune reported on September 9, 2026 that Consensys is dividing into two companies: the consumer-facing MetaMask wallet becomes independent under CEO Joe Lubin, while the institutional software business keeps the Consensys name under CEO Mike Kriak.
Yes. Fortune's September 9, 2026 report said Consensys had signaled plans a year earlier to go public in early 2026, but those plans were shelved amid a crypto-market downturn. No new date was confirmed at the time of the split announcement.
Not through a public exchange. MetaMask is not currently a publicly traded company, and any private-share offer you encounter should be verified independently before you rely on it. Segmara does not sell, broker, or arrange purchases of MetaMask shares.
Next step
If this article helped explain MetaMask, start with the free tracker: indicative pre-IPO marks by email. No card, no documents, no brokerage account, and no allocation promise.
When a full account makes sense, Segmara can route limited interest into an account-based private follow-up. Availability, pricing, eligibility, allocation, transfer approval, liquidity, and final terms can vary by company and route.
Get the free tracker